Celldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Year: 2023
Celldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Freeline to Present at 2023 Jefferies Healthcare Conference
LONDON, June 02, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…
Freeline to Present at 2023 Jefferies Healthcare Conference
LONDON, June 02, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
ARLINGTON, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical…
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
ARLINGTON, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical…
Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference
IRVINE, Calif., June 02, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical Trial Matching for Cancer Patients Worldwide
NEW YORK–(BUSINESS WIRE)–Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology,…
Yangaroo and WideOrbit streamline Traffic Instructions between Advertisers and Broadcasters
TORONTO and SAN FRANCISCO, June 02, 2023 (GLOBE NEWSWIRE) — YANGAROO Inc. (“Yangaroo,” “Company”), (TSX-V:…
Plurilock Announces Sale Order of Flagship AI-Driven Cybersecurity Platform with Overseas Healthcare Administrative Services Provider
The Customer will license the Company’s high-margin software offering, Plurilock AI Vancouver, British Columbia–(Newsfile Corp….
Public Bitcoin Miner SATO Technologies Corp. Releases May 2023 Bitcoin Mining Operational Update and Provides Updates for AI and HPC Deployments
Toronto, Ontario–(Newsfile Corp. – June 2, 2023) – SATO Technologies Corp. (TSXV: SATO) (OTCQB: CCPUF)…
American Aires Inc. Announces ASM Voting Results
Toronto, Ontario–(Newsfile Corp. – June 2, 2023) – American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF)…
KB Home Announces the Grand Opening of Its Newest Community in Patterson, California
Acacia at Patterson Ranch offers personalized, new single-story homes close to desirable schools and outdoor…
MarineMax Expands in the Midwest With the Addition of C&C Boat Works
Significant storage capacity complements MarineMax’s other locations in the region CLEARWATER, Fla.–(BUSINESS WIRE)–MarineMax, Inc. (NYSE:…
Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023
Self-aware solutions making mass spectrometry more accessible SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A)…
Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer
Mr. Ramanayake brings expertise and leadership in oncology business development as the Company advances its…